Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Lucid Diagnostics (LUCD)

Lucid Diagnostics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LUCD
DateTimeSourceHeadlineSymbolCompany
20/12/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUCDLucid Diagnostics Inc
19/12/202413:01PR Newswire (US)Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for FirefightersNASDAQ:LUCDLucid Diagnostics Inc
11/12/202413:01PR Newswire (US)Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed PublicationNASDAQ:LUCDLucid Diagnostics Inc
06/12/202421:10Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:LUCDLucid Diagnostics Inc
03/12/202413:01PR Newswire (US)Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term MilestonesNASDAQ:LUCDLucid Diagnostics Inc
29/11/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUCDLucid Diagnostics Inc
20/11/202412:56PR Newswire (US)Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA TestNASDAQ:LUCDLucid Diagnostics Inc
18/11/202422:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUCDLucid Diagnostics Inc
18/11/202413:15PR Newswire (US)Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:LUCDLucid Diagnostics Inc
14/11/202413:01PR Newswire (US)PAVmed Provides Business Update and Third Quarter 2024 Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
13/11/202413:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUCDLucid Diagnostics Inc
13/11/202413:01PR Newswire (US)Lucid Diagnostics Provides Business Update and Third Quarter 2024 Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
12/11/202421:36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LUCDLucid Diagnostics Inc
12/11/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUCDLucid Diagnostics Inc
07/11/202413:01PR Newswire (US)Lucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed PublicationNASDAQ:LUCDLucid Diagnostics Inc
05/11/202413:01PR Newswire (US)Lucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue DriversNASDAQ:LUCDLucid Diagnostics Inc
31/10/202412:31PR Newswire (US)PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024NASDAQ:LUCDLucid Diagnostics Inc
30/10/202412:31PR Newswire (US)Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 13, 2024NASDAQ:LUCDLucid Diagnostics Inc
15/10/202411:51PR Newswire (US)Lucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA TestNASDAQ:LUCDLucid Diagnostics Inc
09/10/202412:01PR Newswire (US)Lucid Diagnostics to Participate in the 2024 Maxim Healthcare Virtual SummitNASDAQ:LUCDLucid Diagnostics Inc
08/10/202411:49PR Newswire (US)Lucid Diagnostics to Join Global Medtech Leaders at The MedTech Conference 2024NASDAQ:LUCDLucid Diagnostics Inc
01/10/202412:01PR Newswire (US)Lucid Diagnostics Holds Inaugural #CheckYourFoodTube Precancer Testing Event for Former NFL PlayersNASDAQ:LUCDLucid Diagnostics Inc
24/09/202412:01PR Newswire (US)American Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer TestNASDAQ:LUCDLucid Diagnostics Inc
16/09/202420:30PR Newswire (US)PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing RequirementsNASDAQ:LUCDLucid Diagnostics Inc
10/09/202411:56PR Newswire (US)Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World CongressNASDAQ:LUCDLucid Diagnostics Inc
03/09/202411:51PR Newswire (US)Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile HealthNASDAQ:LUCDLucid Diagnostics Inc
20/08/202412:16PR Newswire (US)Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and CancerNASDAQ:LUCDLucid Diagnostics Inc
13/08/202412:16PR Newswire (US)The American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection of Esophageal CancerNASDAQ:LUCDLucid Diagnostics Inc
13/08/202412:01PR Newswire (US)PAVmed Provides Business Update and Second Quarter 2024 Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
12/08/202412:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LUCDLucid Diagnostics Inc
 Showing the most relevant articles for your search:NASDAQ:LUCD